ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Why Research Sites Don't Use EMR As The Source Data Collection Tool

  Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.

• Rewriting The Rules Of Clinical Trials Through Digital Biomarkers

  Digital biomarkers are reshaping clinical research with continuous, real‑world data. Explore how emerging tools, AI, and cross‑industry collaboration are driving smarter clinical development.

• Accelerating Site Activation: Examples From Novartis And IQVIA

  As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

• Paper COAs In 2026? It's Not "Cheaper," It's Riskier

  Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

• Reducing Supply Risk in Cell & Gene Therapy Trials

  In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.

• Don't Just Swap The Engine. Redesign The Factory.

  Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.

• Analyzing The FDA's Approach To Diversity In Clinical Trials

  Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.

• 3 Key Functions Your eTMF Needs To Meet New EMA Regulations

  The European Union Clinical Trial Regulation No. 536/2014 recently introduced the most significant changes to the processes for clinical trial applications in at least the past 15 years. Learn how this impacts the Trial Master File and consider three key functions that an electronic TMF must have to achieve compliance and maintain organizational success.

• Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch

  The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.

• How FAIR Data Principles Deliver Clinical Success

  Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.